Diabetes Solutions Landscape Phase 4, US Clean up and KPIs

Part
01
of nine
Part
01

Diabetes Solutions Landscape, US Round 2 Clean Up

Information related to the two Digital health products, Bluedrop device, and the mySugar app has been updated into the attached spreadsheet.

Bluedrop

Bluedrop Medical has developed a device that can help to "detect diabetic foot ulcers early when treatment is easier". The company has won the award for "Best AI Application in Healthcare for their innovative ulcer detection device at the recent AIconics Awards held in London".

Inclusion criteria 1 -NO

The Bludrop Medical Device is in pre-marketing stage seeking more funding to get FDA approval as well as expand its market. We did not find any information whether the device is currently available in the market in the UK or in any other country.

inclusion criteria 4 -NO

We did not find any piece of information detailing about the clinical research for Bluedrop Medical device. According to a recent article published in January 2018, "the company is in talks with the NHS about implementing the system, and is examining two sites in the US as a possible pilot once the technology has been approved". The Bluedrop Medical has raised €600,000 ($7,41,834) and planned to manufacture its device in Ireland.

The article states that the Bluedrop device is looking for funding "to support product development and trials through FDA approval".

We have entered NO in column A (line 29) as the Bluedrop does not meet the inclusion criteria 1 & 4. Please see the details in the attached spreadsheet.


MySugar

mySugar, "a logbook app is easy and complete diabetes tracker". The app helps people with diabetes to log and monitor their daily blood sugar level, record insulin dose, and track carbohydrate count.

According to the website, mySugar is "a smart diabetes companion that’s there for you anytime, anywhere and for free. Face the challenges of diabetes with confidence!"

mySugar Junior, "a logbook app specially developed for children with diabetes and their caregivers". According to mySugar, they have closed its mySugr junior app as "the new operating system requires a much higher quality of graphics than the Junior app is built with, and it is no longer compatible".

As per an article, mySugar is the most popular diabetes app in the world and "has officially passed over one million registered users". It has raised a total of $6,600,000 and the last round of funding was Seed round. mySugar has received $4,800,000 million from Roche Ventures and iSeed Ventures.

It was mentioned in a press release that Roche has acquired the leading mobile diabetes platforms, mySugr.

As requested, we have updated the line 35 for mySugr. Please see the details in the attached spreadsheet.

Conclusion

As per your instructions, we have gone through the entries for line 29 and line 35 for Bluedrop and mySugar Junior. We found that Bludrop does not meet the inclusion criteria 1 & 4. So, we have updated the spreadsheet with the relevant information in line 29.

For mySugar Junior (line 35), we have updated the name of the app as 'mySugar' and all other information related to the app in the attached spreadsheet.

Part
02
of nine
Part
02

Diabetes Solutions Landscape KPI - My Sugr

All the requested information has been detailed and provided in row 35, columns T-AO on the US2 tab of the attached spreadsheet.
Part
03
of nine
Part
03

Diabetes Solutions Landscape KPI - DayTwo

All the requested information has been detailed and provided in the provided spreadsheet.
Part
04
of nine
Part
04

Diabetes Solutions Landscape KPI - Preventicus

Please see the attached spreadsheet for further details.
(Line 30: T-AO on US2 tab).
Part
05
of nine
Part
05

Diabetes Solutions Landscape KPI - DietSensor

Please see the attached Line 65 in this spreadsheet.
Part
06
of nine
Part
06

Diabetes Solutions Landscape KPI - Clickotine

Clickotine is a smoking cessation app, which allows users to customize a personal plan to aid in the process of quitting smoking. The solution is marked by high user satisfaction and has over 500 downloads since it's launch. The app is available in English only at this time. The solution has undergone five rounds of financing and has generated $8.4 million in revenue to date. Click Therapeutics, the parent company, has produced studies to validate the efficacy of the solution. At the conclusion of their study, 45.2% of the participants (n=188) had quit smoking, which is described as no cigarette use for a minimum of seven days. After six months, 35.3% of the participants (n=147) had quit smoking, which is described as no cigarette use for a minimum of 30 days. A medical device class is not available due to Clickotine being an app, meaning that it is not considered as a medical device.

The majority of information was described in detail on the solution website. Additional information was provided by the parent company, association websites, Google play. All detailed information is available in the attached spreadsheet.
Part
07
of nine
Part
07

Diabetes Solutions Landscape KPI - Sweatcoin

Sweatcoin is a physical activity-tracking crypto-currency app. The mission of Sweatcoin is to facilitate user's increase in physical activity and subsequently aid in combating the global cost of the current obesity problem. Detailed information for each category is accessible on the attached spreadsheet.

Despite extensive searching through press releases, media coverage, company publications, government websites, association websites, and other sources, no evidence was found of regulatory approval or of endorsement by one of the listed medical associations. No medical device class is available for Sweatcoin as it is a crypto-currency app and not considered a medical device.

Sweatcoin has successfully raised 6.3 million dollars in the second round of financing. This round was led by Goodwater Capital and had the active participation of Rubylight, Greylock Partners, and Seed Camp.

Sweatcoin is currently only available in English as an iOS app. The app has maintained a 4.7K user rating. Success of Sweatcoin is measured by user activity increasing from 9-20 percent over the short period of six months.

Part
08
of nine
Part
08

Diabetes Solutions Landscape KPI - Carrot

Carrot Inc. is a digital health company which has developed a smoking cessation app named as 'Pivot'. The app received FDA clearance in November 2017. Carrot is now working with another tech firm, RedBrick Health to expand its launch into the US market.

As requested, a more comprehensive look into the apps Key Performance Indicators (KPI) has been detailed in row 72, columns T-AO of the attached spreadsheet.

During my research, I found that the name of the app and the name of company has been misinterpreted. 'Carrot' is the name of the company that developed the app for people help them quit smoking. The name of the app is 'Pivot' which is considered as a flagship product of Carrot Inc. It is "a tech-enabled smoking-cessation platform" which provides "an OTC carbon monoxide breath sensor, consumer-grade smartphone app, human coaching, and innovative approach to behavioral science". Based on my research, I have updated the name of the app in the spreadsheet.
Part
09
of nine
Part
09

Diabetes Solutions Landscape KPI - Livongo

Livongo is an app that that users have been primarily using the app for information around diabetes, high blood pressure, nutrition, and how to lead a healthy lifestyle (Healthy recipes, lifestyle tips, articles etc). Users use the same to check their sugar trends, weekly summaries and progress charts. It is marketed towards diabetics and is available only in English. The FDA, nor any other organizations (as could be found), regulate this particular app. Across GooglePlay and iTunes, the Livongo app had, as of the writing of this brief, 56 ratings. On GooglePlay, the app had an average rating of 4.7. On iTunes, the app had an average rating of 3.2.

The app was launched in partnership with Voluntis a company that develops companion apps for medical devices.
For the full findings and analysis, please consult Row 64, T- A0 in the US tab of the attached spreadsheet.
Sources
Sources

From Part 01